mevociclib

N/A

Report date: 2022/08/16 20:00:19
NME

Base Information

Drug Namemevociclib
Drug Alias NameSY-1365
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 7 inhibitors
TargetsCyclin-dependent kinase 7
Therapy Area/IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesFrance
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSyros Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSyros Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsSolid tumoursOvarian NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A